Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts American Uranium December 16, 2025 Crypto Market Update: UK Moves To Place Crypto Firms Under FCA Regulation December 16, 2025 Angkor Resources Signs Letter of Intent to Sell Evesham Oil Production December 16, 2025